PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology, Department of Pediatrics, Children\'s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Lupus Center of Excellence, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: asawalha@pitt.edu.\', \'Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China; Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.\', \'Division of Rheumatology, Department of Pediatrics, Children\'s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA; Graduate Immunology Program, University of Michigan School of Medicine, Ann Arbor, MI, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(20)30239-410.1016/j.clim.2020.108410
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 32276140
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all